Lexicon Pharmaceuticals is a fully integrated biopharmaceutical company that is applying a unique approach to gene science based on Nobel Prize-winning technology to discover and develop precise medicines for people with serious, chronic conditions. Using a patient driven approach, they are working to discover and develop innovative medicines to safely and effectively treat disease and improve patient lives.
That couldn’t align more with JDRF’s strive of Improving Lives. Curing Type 1 Diabetes.

Lexicon’s passion is to bring medicines to the market that have the potential to improve the standard of care for diseases that have not experienced new treatment innovation in years – decades, in some cases. They are not driven by any particular disease area or patient population. Rather, using their roadmap of precise targets, they intentionally seek out relatively unexplored mechanisms. Their approach may not be the easiest path, but they believe that, in the long-term, it will ultimately provide the greatest benefit to patients.
This parallels JDRF goals to do the greatest amount of good for the largest amount of people in the shortest amount of time.

Lexicon believes in treating people, not just diseases. Their focus is patient driven and they are committed to listening, assisting and working with patient communities to best serve the patient. Their goal is to generate truly impactful solutions for patients that will make meaningful, long-term improvements in their lives.

The two pillars of our shared (JDRF core) values, Innovative and Passionate, are bridged by a third value, Collaborative – bringing us together in a natural partnership to achieve similar missions. It all started in 2012, when Lexicon joined us with a $500 sponsorship at our inaugural One Walk in the Woodlands, then known as the Greater Montgomery County Walk. As our Walk grew, so did Lexicon’s support to $2500 sponsorships in 2014 and 2015. One Walk Woodlands celebrated our 5th anniversary in 2016, with Lexicon standing up and out as our first ever $20,000 Presenting Sponsor.

Our two teams have worked closely and collectively since then, and just to highlight a couple of memorable moments: Lexicon graciously opened up their pristine office in April to our TID youth ambassadors for their annual Promise Ball photo shoot, going so far as to commission a piece of artwork the ambassadors created there the same day. Just this past August, we had the pleasure and privilege of David Powell, M.D., Senior Vice President, Metabolism Research, speaking at our One Walk, Houston kickoff: Progress to Type None.

The momentum continues to build, and we are thrilled to announce LEXICON PHARMACEUTICALS as our 2017 Presenting Sponsor for BOTH our One Walks, Houston and Woodlands!

“Every year, thousands of people in and around Houston gather to raise awareness and support for the type one community. The outpouring of support is tremendous and grows each year and Lexicon is so honored to be a long-standing sponsor of the JDRF walks and what they represent for our community”, said Chas Schultz, head of corporate communications and patient advocacy at Lexicon Pharmaceuticals.

Another JDRF core value is Appreciative – it would be putting it mildly when we simply tell you: Lexicon, we THANK YOU.